849 related articles for article (PubMed ID: 25775353)
1. Age, Sex, and APOE ε4 Effects on Memory, Brain Structure, and β-Amyloid Across the Adult Life Span.
Jack CR; Wiste HJ; Weigand SD; Knopman DS; Vemuri P; Mielke MM; Lowe V; Senjem ML; Gunter JL; Machulda MM; Gregg BE; Pankratz VS; Rocca WA; Petersen RC
JAMA Neurol; 2015 May; 72(5):511-9. PubMed ID: 25775353
[TBL] [Abstract][Full Text] [Related]
2. Association of β-Amyloid and Apolipoprotein E ε4 With Memory Decline in Preclinical Alzheimer Disease.
Lim YY; Kalinowski P; Pietrzak RH; Laws SM; Burnham SC; Ames D; Villemagne VL; Fowler CJ; Rainey-Smith SR; Martins RN; Rowe CC; Masters CL; Maruff PT
JAMA Neurol; 2018 Apr; 75(4):488-494. PubMed ID: 29356823
[TBL] [Abstract][Full Text] [Related]
3. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
[TBL] [Abstract][Full Text] [Related]
4. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
Yi D; Lee DY; Sohn BK; Choe YM; Seo EH; Byun MS; Woo JI
Am J Geriatr Psychiatry; 2014 Oct; 22(10):961-70. PubMed ID: 24495404
[TBL] [Abstract][Full Text] [Related]
5. Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment.
Insel PS; Hansson O; Mattsson-Carlgren N
JAMA Neurol; 2021 Feb; 78(2):229-235. PubMed ID: 33044487
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
Ossenkoppele R; Jansen WJ; Rabinovici GD; Knol DL; van der Flier WM; van Berckel BN; Scheltens P; Visser PJ; ; Verfaillie SC; Zwan MD; Adriaanse SM; Lammertsma AA; Barkhof F; Jagust WJ; Miller BL; Rosen HJ; Landau SM; Villemagne VL; Rowe CC; Lee DY; Na DL; Seo SW; Sarazin M; Roe CM; Sabri O; Barthel H; Koglin N; Hodges J; Leyton CE; Vandenberghe R; van Laere K; Drzezga A; Forster S; Grimmer T; Sánchez-Juan P; Carril JM; Mok V; Camus V; Klunk WE; Cohen AD; Meyer PT; Hellwig S; Newberg A; Frederiksen KS; Fleisher AS; Mintun MA; Wolk DA; Nordberg A; Rinne JO; Chételat G; Lleo A; Blesa R; Fortea J; Madsen K; Rodrigue KM; Brooks DJ
JAMA; 2015 May; 313(19):1939-49. PubMed ID: 25988463
[TBL] [Abstract][Full Text] [Related]
7. Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.
Caselli RJ; Reiman EM; Locke DE; Hutton ML; Hentz JG; Hoffman-Snyder C; Woodruff BK; Alexander GE; Osborne D
Arch Neurol; 2007 Sep; 64(9):1306-11. PubMed ID: 17846270
[TBL] [Abstract][Full Text] [Related]
8. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured by Positron Emission Tomography in Clinically Normal Older Adults.
Buckley RF; Mormino EC; Rabin JS; Hohman TJ; Landau S; Hanseeuw BJ; Jacobs HIL; Papp KV; Amariglio RE; Properzi MJ; Schultz AP; Kirn D; Scott MR; Hedden T; Farrell M; Price J; Chhatwal J; Rentz DM; Villemagne VL; Johnson KA; Sperling RA
JAMA Neurol; 2019 May; 76(5):542-551. PubMed ID: 30715078
[TBL] [Abstract][Full Text] [Related]
9. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
Lim YY; Laws SM; Villemagne VL; Pietrzak RH; Porter T; Ames D; Fowler C; Rainey-Smith S; Snyder PJ; Martins RN; Salvado O; Bourgeat P; Rowe CC; Masters CL; Maruff P
Neurology; 2016 Apr; 86(17):1635-42. PubMed ID: 27029632
[TBL] [Abstract][Full Text] [Related]
10. Association of Apolipoprotein E ε4 With Medial Temporal Tau Independent of Amyloid-β.
Therriault J; Benedet AL; Pascoal TA; Mathotaarachchi S; Chamoun M; Savard M; Thomas E; Kang MS; Lussier F; Tissot C; Parsons M; Qureshi MNI; Vitali P; Massarweh G; Soucy JP; Rej S; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
JAMA Neurol; 2020 Apr; 77(4):470-479. PubMed ID: 31860000
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal Volume Loss, Brain Amyloid Accumulation, and APOE Status in Cognitively Intact Elderly Subjects.
Haller S; Montandon ML; Rodriguez C; Garibotto V; Herrmann FR; Giannakopoulos P
Neurodegener Dis; 2019; 19(3-4):139-147. PubMed ID: 31846965
[TBL] [Abstract][Full Text] [Related]
12. Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals.
Sperling RA; Donohue MC; Raman R; Sun CK; Yaari R; Holdridge K; Siemers E; Johnson KA; Aisen PS;
JAMA Neurol; 2020 Jun; 77(6):735-745. PubMed ID: 32250387
[TBL] [Abstract][Full Text] [Related]
13. Association of Brain Amyloid-β With Slow Gait in Elderly Individuals Without Dementia: Influence of Cognition and Apolipoprotein E ε4 Genotype.
Nadkarni NK; Perera S; Snitz BE; Mathis CA; Price J; Williamson JD; DeKosky ST; Klunk WE; Lopez OL
JAMA Neurol; 2017 Jan; 74(1):82-90. PubMed ID: 27842173
[TBL] [Abstract][Full Text] [Related]
14. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
15. Age-specific and sex-specific prevalence of cerebral β-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50-95 years: a cross-sectional study.
Jack CR; Wiste HJ; Weigand SD; Therneau TM; Knopman DS; Lowe V; Vemuri P; Mielke MM; Roberts RO; Machulda MM; Senjem ML; Gunter JL; Rocca WA; Petersen RC
Lancet Neurol; 2017 Jun; 16(6):435-444. PubMed ID: 28456479
[TBL] [Abstract][Full Text] [Related]
16. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
17. Brain imaging measurements of fibrillar amyloid-β burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE ε4 allele.
Ghisays V; Goradia DD; Protas H; Bauer RJ; Devadas V; Tariot PN; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Caselli RJ; Su Y; Chen K; Reiman EM
Alzheimers Dement; 2020 Apr; 16(4):598-609. PubMed ID: 31831374
[TBL] [Abstract][Full Text] [Related]
18. Frequency of Biologically Defined Alzheimer Disease in Relation to Age, Sex,
Therriault J; Pascoal TA; Benedet AL; Tissot C; Savard M; Chamoun M; Lussier F; Kang MS; Berzgin G; Wang T; Fernandes-Arias J; Massarweh G; Soucy JP; Vitali P; Saha-Chaudhuri P; Gauthier S; Rosa-Neto P
Neurology; 2021 Feb; 96(7):e975-e985. PubMed ID: 33443136
[TBL] [Abstract][Full Text] [Related]
19. The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects.
Smith R; Strandberg O; Mattsson-Carlgren N; Leuzy A; Palmqvist S; Pontecorvo MJ; Devous MD; Ossenkoppele R; Hansson O
Brain; 2020 Dec; 143(12):3805-3815. PubMed ID: 33439987
[TBL] [Abstract][Full Text] [Related]
20. Midlife insulin resistance,
Ekblad LL; Johansson J; Helin S; Viitanen M; Laine H; Puukka P; Jula A; Rinne JO
Neurology; 2018 Mar; 90(13):e1150-e1157. PubMed ID: 29476033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
